Valentis' technology combines nanocrystalline cellulose (NCC), a biodegradable, transparent material made from plant pulp waste, with additional nanoparticles to produce highly improved polymeric films.
Varian's scientific instruments and vacuum technologies, consumable supplies, and solutions are key tools in bio-molecular and academic research, pharmaceutical R&D and manufacturing, and industrial R&D and quality control.
Vascular Magnetics, Inc. is magnetically targeting drug-loaded biodegradable nanoparticles to develop Vascular Magnetic Intervention (VMI), a novel therapy for peripheral artery disease (PAD). PAD is a common chronic condition characterized by obstruction (stenosis) of the arteries in the legs.
The company is developing Drug-Coated Balloons (DCB) that are designed to be a more precise delivery vehicle and be the standard treatment of choice for vascular atherosclerosis as well as non-vascular applications.
Velocys, Inc. is commercializing revolutionary processing systems, including nanoscale ones, that provide energy companies with new synthetic fuels and chemical companies with substantial capital cost savings, improved product yields, and greater energy efficiencies.
VeriCold Technologies is specialized in cutting-edge X-ray spectroscopy and cooling solutions. Driven by innovative markets (semiconductor, biotechnology and nanotechnology) VeriCold's technology is a key-enabler for new processes in manufacturing, quality control and research.
Vistec Semiconductor Systems' innovative product portfolio includes inspection systems, defect detection and classification, metrology systems for mask and wafer manufacturing. The electron beam systems are used for microchip production and integrated optics as well as for scientific and commercial research.
Offers new culture and exposure systems for in vitro studies of gases or complex mixtures. The VITROCELL modules offer new possibilities for the characterization of the effects of airborne substances such as gases nanoparticles and complex mixtures.